Growing cases of critical care and neonatal intensive care unit admissions are propelling the growth of the global enteral syringe market. According to statistics given by Bliss Organization, over 95,000 newborns are admitted to neonatal units in the U.K, annually due to premature birth (before 37 weeks of pregnancy) or due to full term (after 37 weeks) yet sick birth. Moreover, according to the same source around 1 in every 8 newborns in the U.K are admitted to neonatal units, annually. The increasing geriatric population around the globe is again augmenting the growth of the market.